tert-butyl 3-hydroxy-4,4-dimethylpiperidine-1-carboxylate
|
T635327-1g
|
≥97% |
955028-71-4 |
1g
|
¥ 2875.9
|
期货,请咨询 |
阿拉丁 |
trans-4-(hydroxymethyl)piperidin-3-ol hydrochloride
|
T635326-5g
|
≥97% |
955028-06-5 |
5g
|
¥ 6555.9
|
期货,请咨询 |
阿拉丁 |
trans-4-(hydroxymethyl)piperidin-3-ol hydrochloride
|
T635326-1g
|
≥97% |
955028-06-5 |
1g
|
¥ 2044.9
|
期货,请咨询 |
阿拉丁 |
trans-4-(hydroxymethyl)piperidin-3-ol hydrochloride
|
T635326-10g
|
≥97% |
955028-06-5 |
10g
|
¥ 13110.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (1R,6S)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
T635309-5g
|
≥97% |
951766-54-4 |
5g
|
¥ 25740.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (1R,6S)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
T635309-500mg
|
≥97% |
951766-54-4 |
500mg
|
¥ 3430.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (1R,6S)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
T635309-250mg
|
≥97% |
951766-54-4 |
250mg
|
¥ 2057.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (1R,6S)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
T635309-1g
|
≥97% |
951766-54-4 |
1g
|
¥ 5148.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (1R,6S)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
T635309-100mg
|
≥97% |
951766-54-4 |
100mg
|
¥ 1285.9
|
期货,请咨询 |
阿拉丁 |
3-(氰基甲基)哌啶-1-羧酸叔丁酯
|
T635293-500mg
|
≥97% |
948015-72-3 |
500mg
|
¥ 303.9
|
期货,请咨询 |
阿拉丁 |
3-(氰基甲基)哌啶-1-羧酸叔丁酯
|
T635293-250mg
|
≥97% |
948015-72-3 |
250mg
|
¥ 152.9
|
期货,请咨询 |
阿拉丁 |
3-(氰基甲基)哌啶-1-羧酸叔丁酯
|
T635293-1g
|
≥97% |
948015-72-3 |
1g
|
¥ 536.9
|
期货,请咨询 |
阿拉丁 |
3-(氰基甲基)哌啶-1-羧酸叔丁酯
|
T635293-100mg
|
≥97% |
948015-72-3 |
100mg
|
¥ 130.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R)-2-(2-hydroxyethyl)piperazine-1-carboxylate
|
T635289-5g
|
≥97% |
947275-74-3 |
5g
|
¥ 15157.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R)-2-(2-hydroxyethyl)piperazine-1-carboxylate
|
T635289-500mg
|
≥97% |
947275-74-3 |
500mg
|
¥ 1871.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R)-2-(2-hydroxyethyl)piperazine-1-carboxylate
|
T635289-250mg
|
≥97% |
947275-74-3 |
250mg
|
¥ 940.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R)-2-(2-hydroxyethyl)piperazine-1-carboxylate
|
T635289-1g
|
≥97% |
947275-74-3 |
1g
|
¥ 3046.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R)-2-(2-hydroxyethyl)piperazine-1-carboxylate
|
T635289-100mg
|
≥97% |
947275-74-3 |
100mg
|
¥ 553.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl trans-N-(4-ethynylcyclohexyl)carbamate
|
T635285-5g
|
≥97% |
947141-86-8 |
5g
|
¥ 2370.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl trans-N-(4-ethynylcyclohexyl)carbamate
|
T635285-1g
|
≥97% |
947141-86-8 |
1g
|
¥ 657.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl trans-N-(4-ethynylcyclohexyl)carbamate
|
T635285-10g
|
≥97% |
947141-86-8 |
10g
|
¥ 4717.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[(5-oxopyrrolidin-2-yl)methyl]carbamate
|
T635266-5g
|
≥97% |
944728-08-9 |
5g
|
¥ 2374.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[(5-oxopyrrolidin-2-yl)methyl]carbamate
|
T635266-1g
|
≥97% |
944728-08-9 |
1g
|
¥ 790.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[(5-oxopyrrolidin-2-yl)methyl]carbamate
|
T635266-10g
|
≥97% |
944728-08-9 |
10g
|
¥ 4128.9
|
期货,请咨询 |
阿拉丁 |